विधियों की तुलना करें

	थायरॉइड आई डिजीज क्वालिटी ऑफ लाइफ प्रश्नावली (TED-QoL / GO-QoL)	हाइपरथायरायडिज्म लक्षण प्रश्नावली
क्षेत्र	अंतःस्रावी विज्ञान	अंतःस्रावी विज्ञान
परिवार	Process / pipeline	Process / pipeline
उद्भव वर्ष	2001	1997
प्रवर्तक	Caroline Terwee, Markus Gerding, Frank Dekker	Multiple authors; consensus from Endocrine Society
प्रकार	Patient self-report questionnaire	Patient self-report symptom checklist
मौलिक स्रोत	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.	Engel, G. L., Dayan, A. D., Thorn, G. W., et al. (1997). Hyperthyroidism: A multisystem disease with diverse manifestations. Adv Intern Med, 42, 55-91.
उपनाम	GO-QoL, Graves Ophthalmopathy Quality of Life	HSC, Hyperthyroid Symptom Inventory
संबंधित	3	3
सारांश	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.	The Hyperthyroidism Symptom Checklist is a structured assessment tool for quantifying the symptom burden of Graves' disease and other thyrotoxicosis conditions. It captures the multisystem manifestations of excess thyroid hormone: cardiovascular (palpitations, tachycardia, arrhythmia), neuropsychiatric (anxiety, tremor, insomnia), metabolic (heat intolerance, weight loss, appetite), and eye-specific symptoms (in Graves' ophthalmopathy). Used in endocrinology practice and clinical trials to monitor disease activity and treatment response.